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ARTICLE
A comparison of Cox and logistic regression for use in
genome-wide association studies of cohort and
case-cohort design
James R Staley1, Edmund Jones1, Stephen Kaptoge1, Adam S Butterworth1,2, Michael J Sweeting1,2,
Angela M Wood1,2 and Joanna M M Howson1 on behalf of the EPIC-CVD Consortium
Logistic regression is often used instead of Cox regression to analyse genome-wide association studies (GWAS) of single-
nucleotide polymorphisms (SNPs) and disease outcomes with cohort and case-cohort designs, as it is less computationally
expensive. Although Cox and logistic regression models have been compared previously in cohort studies, this work does not
completely cover the GWAS setting nor extend to the case-cohort study design. Here, we evaluated Cox and logistic regression
applied to cohort and case-cohort genetic association studies using simulated data and genetic data from the EPIC-CVD study.
In the cohort setting, there was a modest improvement in power to detect SNP–disease associations using Cox regression
compared with logistic regression, which increased as the disease incidence increased. In contrast, logistic regression had more
power than (Prentice weighted) Cox regression in the case-cohort setting. Logistic regression yielded inﬂated effect estimates
(assuming the hazard ratio is the underlying measure of association) for both study designs, especially for SNPs with greater
effect on disease. Given logistic regression is substantially more computationally efﬁcient than Cox regression in both settings,
we propose a two-step approach to GWAS in cohort and case-cohort studies. First to analyse all SNPs with logistic regression to
identify associated variants below a pre-deﬁned P-value threshold, and second to ﬁt Cox regression (appropriately weighted in
case-cohort studies) to those identiﬁed SNPs to ensure accurate estimation of association with disease.
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INTRODUCTION
Cox proportional hazards models are regularly used to analyse time-
to-event data in prospective epidemiological cohort and case-cohort
studies (Supplementary Text). Case-cohort studies are similar to
cohort studies, with the exception that full covariate information is
only collected for those individuals who develop the disease over
follow-up and a randomly selected subgroup of the initial cohort,
referred to as the subcohort (see Supplementary Figure S1). In
contrast to traditional epidemiology, logistic regression is often used
in genome-wide association studies (GWAS) of cohort and case-
cohort data to assess the associations of single-nucleotide polymorph-
isms (SNPs) and disease outcomes, ignoring the time-to-event
information in prospective studies (Supplementary Text).1,2 The
reasons for this include the faster computational time of the logistic
regression model, the lack of implementation of time-to-event analysis
models within most GWAS software and that genetic studies are often
combined in multi-study consortia using meta-analysis in which it is
convenient to analyse both case–control studies and prospective
studies in the same way.
Cox and logistic regression models have been previously compared
in cohort studies3–8 but not in case-cohort studies. For cohort studies,
it was reported that: (i) the Cox model yields more precise estimates of
association; (ii) odds ratios (ORs) and hazard ratios (HRs) diverge as
follow-up time, cumulative disease incidence and the strength of the
association increase; (iii) in certain situations the Cox model has
greater statistical power; and (iv) the Cox model takes a longer time to
compute than the logistic regression model. However, most of these
studies are at least 20 years old when computational power was
limited. Thus, inferences were based on mathematical theory as well as
results from small observational studies, and as such do not fully
answer the relevant questions for modern GWASs, which are large
studies where a small to modest increase in power and precision
would probably be sacriﬁced for an increase in computational
efﬁciency and for practical reasons (such as the availability of suitable
software). A more recent study investigated the differences in power
between these methods (using simulations) for genetic associations of
coronary heart disease (CHD) in a cohort of familial hypercholester-
olaemia patients.9 The Cox model had signiﬁcantly greater power
compared with logistic regression for SNP–CHD associations in this
very high-risk population. However, this study is not generalisable to
cohorts with lower disease incidences. Furthermore, practitioners have
thus far assumed ﬁndings for cohort studies would extrapolate to case-
cohort studies, but this has not been formally investigated.
Hence we investigated the potential gains in power and precision
against the greater computation time of using Cox proportional
hazards models instead of logistic regression models in prospective
cohort and case-cohort genetic studies. We performed a simulation
study, and validated our ﬁndings empirically using SNP–CHD
associations from the EPIC-CVD case-cohort study.
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MATERIALS AND METHODS
In the simulation study, we assessed the performance of the Cox and logistic
regression models (details of these models are given in the Supplementary Text)
in terms of bias, precision and statistical power for cohort and case-cohort
studies. The computational time needed to perform a GWAS using both
models in cohort and case-cohort studies was also assessed using simulated
data. We further compared the Cox and logistic regression models using SNP–
CHD associations in EPIC-CVD for loci that have previously been robustly
associated with CHD.1 All analyses were performed in R (version 3.1.0) on a 24
core Linux server (1.8 GHz, 124Gb RAM).
Simulation study
We simulated survival data under both the cohort and case-cohort study
designs. HR was used as the underlying measure of association and is assumed
to be the reference (or gold) standard, and as such, bias was deﬁned as the
estimated log(HR) or log(OR) minus the underlying log(HR) (i.e. log(H^R)−
log(HR) or log(O^R)− log(HR)). Precision as estimated by the model was
assessed using the standard error (SE) of the estimated log(HR) or log(OR).
Statistical power was deﬁned (at the per SNP-test level) as the percentage of
simulation replications where the SNP–disease association had a P-value less
than the type I error rate of α= 0.05.
We considered various combinations of sample size, risk allele frequency
(RAF), cumulative disease incidence (proportion of individuals who experi-
enced the disease outcome over the period of follow-up), sampling fraction (for
the case-cohort design) and HRs between a single hypothetical SNP and disease,
assuming a multiplicative allelic effects model. Sample size was varied over
5000, 10 000 and 25 000 for the cohort study design, and the initial cohort was
set to 40 000 for the case-cohort study design. Sampling fractions of 5, 10 and
15% were used in the case-cohort design to generate the subcohort. The
additional cases from the initial cohort were then added to create the case-
cohort data set. Since the differences between the logistic and Cox model are
small for rare diseases,3–5 we selected cumulative disease incidences of 5, 10 and
15% to reﬂect common diseases (e.g. CHD and type II diabetes) often seen over
a 20-year period for the age group studied in the simulations. The RAFs
examined were 0.05, 0.10, 0.25, 0.50, 0.75, 0.90 and 0.95. The strength of the
association was varied over HRs of 1.05, 1.10, 1.15, 1.20, 1.30, 1.50 and 2.00. To
examine the type I error rates of the two approaches, we simulated under an
HR of 1. In each simulation scenario the simulation under the null yielded a
type I error of approximately 0.05 for both the Cox and logistic regression
models (Supplementary Tables S1 and S2).
In each simulation, we constructed a population with an age-structure (in
years) similar to that of EPIC-CVD using a normal distribution with mean 56
and standard deviation 6, where all the individuals were assumed to be of the
same gender and ethnicity. Genotypes were randomly generated according to
the speciﬁed RAF using the binomial distribution.
We used the Weibull distribution (with scale parameter λ40, shape
parameter v40 and hazard function λvtv− 1) to generate event times10 (T)
assuming a causal effect of age and SNP genotype on disease and proportional
hazards,
T ¼ log Uð Þ
lexp bAAþ bGGð Þ
 1=v
where T is survival time (in years); U is a random variable following a uniform
distribution on [0, 1]; A is age measured in years; G is genotype coded as 0, 1 or
2 according to the number of risk alleles that the individual has; βA is the log
(HR) for a 1 year increase in age; and βG is the log(HR) for a one allele increase
in the risk allele. Approximate estimates of βA and λ for CHD (fatal and non-
fatal) were obtained by ﬁtting a Weibull regression model with age as the only
covariate in males from the EPIC-CVD subcohort. βG was set equal to the
logarithm of the HR for the hypothetical SNP in each simulation scenario. The
shape parameter (v) was scaled according to the RAF and underlying HR for
the hypothetical SNP to ensure a number of cases that approximately reﬂects
the cumulative disease incidence in each simulation scenario.
We simulated under three censoring distributions with maximum follow-up
of 20 years. The ﬁrst assumed that all the non-cases had complete follow-up of
20 years ('complete follow-up model'). The second assumed each individual
was equally likely to be censored at one of four surveys: 5, 10, 15 and 20 years
('survey follow-up model'). The third randomly censored individuals across the
20 years of follow-up using a uniform distribution with minimum 0 years and
maximum 20 years ('random follow-up model'). We would expect the
censoring distribution of most studies to lie somewhere in-between these
distributions. Within each simulation, an individual was considered to have
experienced the disease outcome if their event time was less than their
censoring time, and to be disease free otherwise. Their time in the study was
set to be the minimum of their event time and censoring time.
In the primary simulations, we set the cumulative disease incidence to be
either 5, 10 or 15% regardless of the censoring distribution, as model choice is
often solely based on the proportion of cases attained over follow-up. However,
keeping the proportion of cases constant across censoring strategies changes the
disease incidence rate. Hence, we performed a secondary set of simulations
where the survey and random censoring strategies were applied to the event
time distributions from the complete follow-up model.
We analysed the simulated data using Cox and logistic regression models
with genotype and baseline age included as covariates in the model. The Cox
model was ﬁtted using the time-on-study time-scale in both the cohort and
case-cohort simulations. In the case-cohort setting, Prentice weights and robust
SEs were used for the Cox model to account for the sampling process.11,12
Logistic regression in case-cohort studies applied directly to the cases and the
subcohort non-cases gives asymptotic inference of odds ratios.11 Each simula-
tion scenario was repeated 5000 times. The P-values were calculated using
Wald tests.
Computational time
The computational time needed to perform Cox and logistic regression models
was estimated using 10 000 variants (with RAFs between 0.05 and 0.95)
assuming only one of which is causal with an HR between 1 and 2. In the
cohort setting, we used 10 000 simulated individuals. For the case-cohort
setting, we generated the case-cohort in the same way described above using a
sampling fraction of 15% and an initial cohort of 40 000 simulated individuals.
We used the survey follow-up model (see above) and compared the computa-
tional times of the models for cumulative disease incidences of 5, 10 and 15%.
To estimate these computational times we extended GenABEL13 to enable it to
perform Prentice-weighted Cox models. This extension is available on request
from the authors.
Empirical example: SNP–CHD associations in EPIC-CVD
EPIC-CVD is a case-cohort study of 31 050 participants derived from 29
recruitment centres across 10 European studies nested within the EPIC
study.14,15 The subcohort contains 17 640 individuals, of which 631 had an
incident fatal or non-fatal CHD (including angina) event. There were an
additional 13 333 CHD events outside the subcohort. The mean age at baseline
was 55.3 years and 46.9% of the participants are males. Individuals were
genotyped using either the Illumina Cardio-MetaboChip array or the Illumina
660W-Quad BeadChip array. In total, 18 889 individuals had genetic informa-
tion. We analysed 25 SNPs located within known CHD loci, which were
genotyped on both arrays and were available in at least 95% of the genotyped
individuals. A multiplicative allelic effects model (on the HR/OR scale) was
assumed for the SNPs, and we adjusted for age (in years), sex, EPIC-CVD
centre (as a categorical variable) and 10 principal components to adjust for
ancestry. Age, sex and EPIC centre were used as covariates to account for
differences across EPIC centres (including any differences in the distributions of
age and sex). We compared the associations from the Cox and logistic
modelling approaches in the full EPIC-CVD case-cohort and in the subcohort
of EPIC-CVD (as a surrogate cohort study). The Cox model was ﬁtted using
the time-on-study time-scale in both settings. Prentice weights and robust SEs
were used for the Cox model in the full case-cohort to account for the sampling
process. SNPs were aligned to the plus strand of the human genome reference
sequence and are displayed on version 19 (Build 37) of the human genome.
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RESULTS
Simulation study
Cohort study design. As expected, the power to detect SNP–disease
associations increased as the underlying HR increased for both Cox
and logistic regression models (Table 1 and Supplementary Table S3).
Power also increased as the cumulative disease incidence increased
(Table 1 and Supplementary Table S3). The Cox model tended to have
more power than logistic regression, and as the cumulative disease
incidence increased this difference in power also increased (Figure 1).
Furthermore, the increase in power for the Cox model was greater in
magnitude as the rate of censoring over the 20 years of follow-up
increased (compare Figures 1a–c), from very small differences in
Table 1 Simulation results for cohort studies with 10,000 individuals for a SNP with RAF=0.10.
Cox Regression (HR) Logistic Regression (OR)
True HR Mean(Bias) Mean(SE) Power Mean(Bias) Mean(SE) Power Diff in Power
Complete Follow-up, 5% Cumulative Disease Incidence
1.1 –0.0039 0.1020 0.1610 –0.0010 0.1052 0.1590 0.0020
1.2 –0.0024 0.0985 0.4674 0.0034 0.1018 0.4636 0.0008
1.5 –0.0031 0.0909 0.9856 0.0111 0.0947 0.9858 –0.0002
2 –0.0014 0.0834 1.0000 0.0264 0.0881 1.0000 0.0000
Complete Follow-up, 10% Cumulative Disease Incidence
1.1 –0.0025 0.0716 0.2664 0.0036 0.0764 0.2628 0.0036
1.2 –0.0006 0.0694 0.7360 0.0114 0.0744 0.7342 0.0022
1.5 –0.0004 0.0642 0.9998 0.0290 0.0699 0.9998 0.0000
2 –0.0005 0.0586 1.0000 0.0576 0.0655 1.0000 0.0000
Complete Follow-up, 15% Cumulative Disease Incidence
1.1 –0.0008 0.0588 0.3754 0.0087 0.0648 0.3748 0.0006
1.2 –0.0013 0.0570 0.8730 0.0168 0.0633 0.8694 0.0036
1.5 –0.0007 0.0530 1.0000 0.0440 0.0601 1.0000 0.0000
2 –0.0007 0.0487 1.0000 0.0869 0.0574 1.0000 0.0000
Survey Follow-up, 5% Cumulative Disease Incidence
1.1 –0.0006 0.1011 0.1678 0.0020 0.1044 0.1684 -0.0006
1.2 –0.0015 0.0979 0.4668 0.0026 0.1013 0.4576 0.0092
1.5 –0.0043 0.0907 0.9864 0.0065 0.0945 0.9858 0.0006
2 –0.0014 0.0840 1.0000 0.0193 0.0885 1.0000 0.0000
Survey Follow-up, 10% Cumulative Disease Incidence
1.1 –0.0035 0.0716 0.2638 –0.0006 0.0763 0.2550 0.0088
1.2 –0.0016 0.0694 0.7296 0.0057 0.0743 0.7068 0.0228
1.5 –0.0019 0.0645 1.0000 0.0166 0.0700 1.0000 0.0000
2 0.0002 0.0594 1.0000 0.0362 0.0661 1.0000 0.0000
Survey Follow-up, 15% Cumulative Disease Incidence
1.1 –0.0018 0.0590 0.3672 0.0027 0.0650 0.3370 0.0302
1.2 –0.0005 0.0573 0.8760 0.0093 0.0635 0.8472 0.0288
1.5 –0.0011 0.0535 1.0000 0.0219 0.0605 1.0000 0.0000
2 –0.0013 0.0498 1.0000 0.0439 0.0580 1.0000 0.0000
Random Follow-up, 5% Cumulative Disease Incidence
1.1 –0.0038 0.1017 0.1682 –0.0022 0.1049 0.1620 0.0062
1.2 –0.0025 0.0983 0.4638 0.0004 0.1016 0.4574 0.0064
1.5 –0.0031 0.0913 0.9858 0.0049 0.0950 0.9836 0.0022
2 –0.0037 0.0852 1.0000 0.0106 0.0896 1.0000 0.0000
Random Follow-up, 10% Cumulative Disease Incidence
1.1 –0.0018 0.0721 0.2702 0.0005 0.0768 0.2494 0.0208
1.2 –0.0025 0.0699 0.7324 0.0017 0.0748 0.6898 0.0426
1.5 –0.0029 0.0651 1.0000 0.0078 0.0706 1.0000 0.0000
2 –0.0006 0.0604 1.0000 0.0198 0.0668 1.0000 0.0000
Random Follow-up, 15% Cumulative Disease Incidence
1.1 –0.0016 0.0589 0.3614 –0.0003 0.0648 0.3240 0.0374
1.2 –0.0012 0.0572 0.8786 0.0031 0.0634 0.8282 0.0504
1.5 –0.0011 0.0536 1.0000 0.0091 0.0605 1.0000 0.0000
2 –0.0008 0.0502 1.0000 0.0184 0.0582 1.0000 0.0000
Abbreviations: Diff in Power, difference in power (Cox − logistic); HR, hazard ratio; OR, odds ratio; RAF, risk allele frequency; SE, standard error of the logarithm of hazard or odds ratio. Bias refers
to either the estimated log(HR) or log(OR) minus the underlying log(HR). It is important to note that HRs and ORs are different measures of comparison and as such ORs are not ’biased‘ if different
from the underlying HR. This table is a subset of Supplementary Table S3.
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power for the complete follow-up model (o1%) to larger differences
(up to 7%) for the random follow-up model.
The mean bias for the Cox model was approximately zero across all
the simulation scenarios (Table 1 and Supplementary Table S3).
However, the estimated ORs were on average larger than the under-
lying HRs, especially for larger effect sizes. There was also a larger
degree of divergence between the HRs and the ORs as the length of
follow-up time increased (average follow-up time: complete follow-up
model= 19.1 years; survey follow-up model= 11.9 years; random
follow-up model= 9.4 years), and as the cumulative disease incidence
increased (Table 1 and Supplementary Table S3). The HRs were more
precise (as estimated by the model) than the ORs across all scenarios,
and this relative difference in precision was positively correlated with
cumulative disease incidence (Table 1 and Supplementary Table S3).
This increase in precision offsets the greater effect sizes of the logistic
regression model, and hence leads to the greater differences in power
between the Cox and logistic regression models for the larger
cumulative disease incidences (Figure 1).
The differences in power between the Cox and logistic regression
models were reasonably similar across the RAFs for each of the
combinations of cumulative disease incidence and censoring strategy
(Supplementary Figures S2–S4). In the secondary simulations, where
the survey and random follow-up censoring strategies were applied to
the event time distributions from the complete follow-up model, there
was less divergence between the HRs and ORs as the rate of censoring
increased (Supplementary Table S4). This decreased divergence, when
censoring was introduced, led to a small increase in the greater power
of the Cox model for the larger cumulative disease incidences
(Supplementary Table S4).
Case-cohort study design. The absolute power increased as the
underlying effect size increased for both modelling approaches
(Table 2 and Supplementary Table S5). These power curves were
steeper as the disease incidence and sampling fraction (which increases
the sample size) increased for both models. However, for the case-
cohort study design, we found a large decrease in power when using
the Prentice-weighted Cox model compared with logistic regression.
This loss of power worsened as the cumulative disease incidence
increased and as the amount of censoring increased over the 20 years
(Figure 2).
The mean bias was approximately zero for the Cox model across all
of the scenarios. However, the ORs from the logistic regression model
tended to be larger than the underlying HR, and this difference
increased as the underlying HR and the length of follow-up increased
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Figure 1 Difference in power between the Cox and logistic regression models for an SNP with a risk allele frequency of 10% for the cohort study design. The
red, blue and green lines represent the sample sizes 5000, 10 000 and 25 000, respectively. Complete (a), Survey (b) and Random (c) are the types of
follow-up and 5, 10 and 15% are the cumulative disease incidences.
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(Table 2 and Supplementary Table S5). In contrast to the cohort
simulations, the HRs were not consistently more precise than the ORs.
The mean SEs were smaller for the logistic regression model than the
Cox model in the survey and random follow-up models but were
slightly larger for the complete follow-up model (Table 2 and
Supplementary Table S5). This increased precision of the logistic
regression model relative to the Cox model in case-cohort studies
(compared with cohort studies) occurs because robust SEs were not
required for the logistic regression model but they were for the Cox
model to account for the sampling process of this study design. The
HRs also became less precise as the average length of follow-up time
decreased. For instance, the mean SE of the logarithm of the estimated
HR for the sampling fraction of 10%, RAF= 0.10, cumulative disease
incidence of 10% and underlying HR of 1.10 were 0.052, 0.056 and
Table 2 Simulation results for case-cohort studies with sampling fraction of 10% from 40,000 individuals for a SNP with RAF=0.10.
Cox Regression (HR) Logistic Regression (OR)
True HR Mean(Bias) Mean(SE) Power Mean(Bias) Mean(SE) Power Diff in Power
Complete Follow-up, 5% Cumulative Disease Incidence
1.1 –0.0007 0.0635 0.3284 0.0021 0.0647 0.3318 –0.0034
1.2 –0.0002 0.0622 0.8308 0.0053 0.0634 0.8392 –0.0084
1.5 0.0010 0.0596 1.0000 0.0143 0.0608 1.0000 0.0000
2 0.0007 0.0582 1.0000 0.0259 0.0588 1.0000 0.0000
Complete Follow-up, 10% Cumulative Disease Incidence
1.1 0.0001 0.0524 0.4480 0.0054 0.0542 0.4580 –0.0100
1.2 0.0006 0.0517 0.9430 0.0119 0.0536 0.9522 –0.0092
1.5 –0.0001 0.0505 1.0000 0.0270 0.0524 1.0000 0.0000
2 0.0004 0.0503 1.0000 0.0531 0.0518 1.0000 0.0000
Complete Follow-up, 15% Cumulative Disease Incidence
1.1 0.0011 0.0484 0.5126 0.0098 0.0510 0.5402 –0.0276
1.2 –0.0008 0.0481 0.9674 0.0161 0.0507 0.9782 –0.0108
1.5 0.0003 0.0475 1.0000 0.0418 0.0504 1.0000 0.0000
2 0.0022 0.0479 1.0000 0.0816 0.0507 1.0000 0.0000
Survey Follow-up, 5% Cumulative Disease Incidence
1.1 0.0002 0.0659 0.3120 0.0027 0.0643 0.3378 –0.0258
1.2 0.0008 0.0647 0.8050 0.0049 0.0631 0.8402 –0.0352
1.5 –0.0002 0.0624 1.0000 0.0094 0.0607 1.0000 0.0000
2 0.0015 0.0612 1.0000 0.0195 0.0590 1.0000 0.0000
Survey Follow-up, 10% Cumulative Disease Incidence
1.1 –0.0004 0.0569 0.3786 0.0026 0.0541 0.4350 –0.0564
1.2 0.0009 0.0563 0.9038 0.0076 0.0536 0.9422 –0.0384
1.5 0.0007 0.0553 1.0000 0.0171 0.0525 1.0000 0.0000
2 0.0024 0.0551 1.0000 0.0334 0.0519 1.0000 0.0000
Survey Follow-up, 15% Cumulative Disease Incidence
1.1 0.0019 0.0542 0.4332 0.0064 0.0510 0.5130 –0.0798
1.2 –0.0005 0.0538 0.9294 0.0089 0.0507 0.9682 –0.0388
1.5 0.0016 0.0533 1.0000 0.0230 0.0504 1.0000 0.0000
2 0.0008 0.0535 1.0000 0.0424 0.0506 1.0000 0.0000
Random Follow-up, 5% Cumulative Disease Incidence
1.1 –0.0007 0.0681 0.2864 –0.0001 0.0645 0.3212 –0.0348
1.2 0.0005 0.0670 0.7768 0.0030 0.0633 0.8334 –0.0566
1.5 –0.0005 0.0648 1.0000 0.0067 0.0609 1.0000 0.0000
2 0.0007 0.0639 1.0000 0.0143 0.0593 1.0000 0.0000
Random Follow-up, 10% Cumulative Disease Incidence
1.1 0.0006 0.0599 0.3536 0.0021 0.0543 0.4290 –0.0754
1.2 –0.0005 0.0593 0.8756 0.0037 0.0537 0.9398 –0.0642
1.5 0.0004 0.0583 1.0000 0.0097 0.0526 1.0000 0.0000
2 0.0004 0.0583 1.0000 0.0192 0.0520 1.0000 0.0000
Random Follow-up, 15% Cumulative Disease Incidence
1.1 –0.0002 0.0574 0.3740 0.0016 0.0509 0.4726 –0.0986
1.2 0.0021 0.0571 0.9062 0.0055 0.0507 0.9578 –0.0516
1.5 0.0004 0.0566 1.0000 0.0112 0.0503 1.0000 0.0000
2 0.0031 0.0571 1.0000 0.0199 0.0505 1.0000 0.0000
Abbreviations: Diff in Power, difference in power (Cox − logistic); HR, hazard ratio; OR, odds ratio; RAF, risk allele frequency; SE, standard error of the logarithm of hazard or odds ratio. Bias refers
to either the estimated log(HR) or log(OR) minus the underlying log(HR). It is important to note that HRs and ORs are different measures of comparison and as such ORs are not 'biased' if different
from the underlying HR. The Cox model was Prentice weighted and robust SEs were applied to account for the sampling process. This table is a subset of Supplementary Table S5.
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0.060 for the complete, survey and random follow-up models,
respectively. These large differences in precision between the censoring
strategies were caused by the smaller amount of information from the
subcohort contributing to the pseudo-likelihood at each failure as the
amount of censoring increased. As expected, the distributions of the
ORs were similar across the censoring strategies as there were
approximately the same number of cases and non-cases across the
censoring strategies for the same cumulative disease incidence. Hence,
the greater precision of the logistic regression model compared with
the Cox model for the random and survey follow-up models leads to
the larger differences in power for these models. The increased power
of the logistic regression model in the complete follow-up model was
mainly driven by the larger effect estimates of the logistic
regression model.
The differences in power between the Cox model and the logistic
regression models were relatively similar across the RAFs for each of
the combinations of cumulative disease incidence and censoring
strategy (Supplementary Figures S5–S7). In the secondary simulations,
where the event time distributions were kept consistent across the
censoring strategies, we observed that there was less divergence
between the HRs and ORs as the rate of censoring increased
(Supplementary Table S6). There was also a small increase in the
difference in power between the two models when there was censoring
(Supplementary Table S6). This occurred because, unlike when there
was no censoring, the logistic regression model was now more precise
than the Cox model (Supplementary Table S6).
Computational time
The computational time required to complete a genetic association
study of 10 000 SNPs using the Cox model was approximately 18
times greater than the equivalent analysis using logistic regression for
cohort studies (cohort size of 10 000), regardless of the cumulative
disease incidence (Supplementary Table S7). Similarly, the computa-
tional time needed to analyse 10 000 SNPs with the Cox model was at
least 190 times greater than the same analysis using logistic regression
for case-cohort studies (sampling fraction of 15%; initial cohort of
40 000). We expect these relative differences in computational time
between the models to remain the same for data sets with greater
numbers of SNPs.
Empirical example: SNP–CHD associations in EPIC-CVD
To assess Cox and logistic regression models in cohort studies, we
used the subcohort of EPIC-CVD and 25 SNPs from known CHD
loci. Since there were only 437 CHD events in the individuals
D
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Figure 2 Difference in power between the Cox and logistic regression models for an SNP with a risk allele frequency of 10% for the case-cohort study
design. The red, blue and green lines represent the sampling fractions of 5, 10 and 15%, respectively. Complete (a), Survey (b) and Random (c) are the
types of follow-up and 5, 10 and 15% are the cumulative disease incidences.
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genotyped in the subcohort, there was limited power to detect SNP–
CHD associations in the subcohort with either model. Nevertheless, in
the subcohort the effect estimates were directionally concordant for
the Cox and logistic regression models for 24 of the 25 SNPs (Table 3),
and the SNP that was directionally discordant had effect estimates very
close to the null for both models. Of the 24 concordant SNPs, 18 had
the same direction of effect as in the literature (Supplementary
Table S8).1,2 The SNPs that showed different directions of association
with the literature were in general those SNPs with smaller effect on
CHD and hence required large sample sizes to detect these effects
(Supplementary Table S8). The Cox model was more precise than
logistic regression for all of the SNPs and for the effect sizes further
away from the null the ORs tended to be larger in magnitude
(Table 3).
We assessed Cox and logistic regression models in case-cohort
studies by using the entire EPIC-CVD case-cohort and the same 25
SNPs as above. Here, the effect estimates were directionally con-
cordant for both models for 22 of the 25 SNPs (Table 3), of which 21
had the same direction of effect as in the literature (Supplementary
Table S8). Like in the subcohort, the effect estimates of the SNPs that
were directionally discordant between the models lie close to the null
and the SNP that was directionally discordant with the literature
had a small effect on CHD in the large consortia (Supplementary
Table S8). The logistic regression model was more precise than the
Cox model for all of the SNPs often leading to much smaller P-values.
For instance, the SNP rs974819 (chr11:g.103660567C4T; an SNP
located downstream of PDGFD) had similar effect sizes for the Cox
(log(HR)=− 0.082) and logistic (log(OR)=− 0.080) regression mod-
els, but the SEs were 0.031 and 0.027, respectively. This led to a
smaller P-value for the logistic regression model (P= 0.003 compared
with P= 0.007). Again, the effect sizes of the logistic regression model
tended to be larger in magnitude than those of the Cox model for the
effect estimates of greater magnitude. Two examples of this are the
SNPs rs9349379 (chr6:g.12903957A4G; an intronic variant in
PHACTR1) and rs2075650 (chr19:g.45395619A4G; an intronic
variant in TOMM40 upstream of APOE) where the effect sizes were
0.03 and 0.013 larger in magnitude for the logistic regression model
compared with the Cox model. This in combination with smaller SEs
for the logistic regression model led to much smaller P-values for this
model (Table 3).
DISCUSSION
In this paper, we have investigated the differences between the Cox
and logistic regression models in cohort and case-cohort studies using
simulations and SNP–CHD associations from EPIC-CVD. In the
simulations, we examined a wide range of scenarios, including varying
the amount of censoring (over a 20-year follow-up period), the RAF of
the SNP, the strength of the association and the number of events (by
changing the cumulative disease incidence). The results from the
EPIC-CVD case-cohort show similar ﬁndings to the simulations. We
believe that this is the ﬁrst study to speciﬁcally compare the Cox and
logistic regression models in case-cohort studies.
We have shown that there is increased power to detect SNP–disease
associations using the Cox model instead of logistic regression for the
cohort study design and the extent to which it has additional power
depends on cumulative disease incidence and the length of follow-up.
However, the increase in power using the Cox model was small when
the cumulative disease incidence was low or when the non-cases had
complete follow-up. We also observed that the ORs and HRs diverge
as follow-up time and cumulative disease incidence increase (especially
for large underlying effects), that the HRs were more precise, and
logistic regression was more computationally efﬁcient. These ﬁndings
are in line with and extend those from previous studies with the
emphasis in the current work being the application of these modelling
approaches in genetic association studies.4,5,7–9
In contrast to the cohort study design, it appears that there is no
additional power to be gained by using Prentice-weighted Cox models
for genetic associations in case-cohort studies. Indeed, there is a striking
loss in power, which occurs because robust SEs are not necessary for
the logistic regression model in addition to its effect estimates being
greater in magintude. Furthermore, the computational cost of the Cox
model was far greater than that of the logistic regression model. Hence,
although we recognise the caveats of using the logistic regression model
(inﬂated effect estimates, especially for associations of greater magni-
tude) in case-cohort studies, we propose that logistic regression could
be used as a ﬁlter to detect SNPs below a pre-deﬁned P-value threshold
for GWAS (of a large number of SNPs (4500 000)) in case-cohort
studies. This threshold should be set suitably high to ensure that all of
the SNPs that would have been detected at the overall level of
signiﬁcance with the Cox model are contained within this subset, for
example, 1 × 10− 4 if the overall signiﬁcance threshold is 5× 10− 8.
Prentice-weighted Cox models could then be ﬁtted to this subset of
SNPs, avoiding the vast computational time required to complete an
entire GWAS using the Prentice-weighted Cox model, while obtaining
accurate estimates of effect and inference (including P-values) for the
SNPs of particular interest. This two-step procedure could also be
applied in the cohort setting to reduce computational time.
We must note here that HRs and ORs are different measures of
association and have different interpretations. Cox models incorporate
the length of time the individuals are followed up and measure
whether the risk factor affects the time at which the disease event
occurs. Logistic regression assesses whether the risk factor affects the
odds of disease, and hence does not take into account the time of
disease occurrence. So early and late failures are given the same weight
in the analysis. In addition, individuals who are not observed to have
the event during the period of follow-up time are treated as controls.
This is different from the time-to-event analysis approaches where
these individuals are considered to be censored. That is, we assume
that all the individuals will have the event at some point but we just do
not observe this event over the follow-up period for some individuals.
Since these models have different deﬁnitions and estimate different
parameters, naturally the results from these models will differ, as
observed in our work.
The results of our simulations and EPIC-CVD analyses are directly
generalisable to diseases with cumulative incidence between 5 and
15% over a 20-year period of follow-up. However, our results could
probably be safely extrapolated to other disease incidences over this
period of follow-up (i.e. the Cox and logistic model estimates will
become increasingly similar as the disease becomes rarer (cumulative
disease incidenceo5%) and will diverge more as the disease becomes
more common (cumulative disease incidence415%)). Additional
avenues of research could include comparing further time-to-event
models (e.g. parametric survival models), examining the effect of
violating the proportional hazards assumption, meta-analysing case–
control studies alongside prospective studies and the inclusion of
prevalent cases in the analysis.
In summary, to minimise computational time in analysing genetic
associations in cohort and case-cohort studies, while obtaining
appropriate estimates of effect for SNPs of greater interest we propose
a two-step procedure. Firstly, logistic regression is used to analyse all
SNPs as an initial ﬁltering process and secondly, Cox regression is
ﬁtted to those SNPs associated below a pre-deﬁned P-value threshold
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to avoid inﬂated estimates of effect as well as to obtain appropriate P-
values for these SNPs. However, logistic regression remains a practical
alternative to Cox models in cohort and case-cohort studies, especially
when the disease incidence is low.
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